Actively Recruiting
Biobank for Inflammatory Chronic Diseases and Osteoporosis
Led by University Hospital, Toulouse · Updated on 2026-03-19
2000
Participants Needed
1
Research Sites
520 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to constitute a biobank for patients followed in the Rheumatology center of Toulouse University Hospital for a chronic inflammatory rheumatism including rheumatoid arthritis (RA), spondyloarthritis(SpA), and psoriatic arthritis (PsA) or a chronic bone disease including osteoporosis in order to identify biomarkers associated with therapeutic response.
CONDITIONS
Official Title
Biobank for Inflammatory Chronic Diseases and Osteoporosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Chronic inflammatory rheumatism including rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis, or patients with primary or secondary osteoporosis
- Have National Health Assurance
- Able to consent to the study
You will not qualify if you...
- Pregnancy or breastfeeding
- Not able to give consent
- Severe anemia (hemoglobin less than 10 g/L)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Purpan University Hospital
Toulouse, France, 31059
Actively Recruiting
Research Team
A
Adeline RUYSSEN-WITRAND, MD
CONTACT
D
Delphine THUILLEZ
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here